162 related articles for article (PubMed ID: 26359557)
21. Pulmonary tumor embolism derived from stomach cancer observation with serial 18F-FDG PET/CT.
Shin S; Pak K; Kim SJ; Kim H; Kim SJ
Clin Nucl Med; 2015 Mar; 40(3):270-2. PubMed ID: 25247270
[TBL] [Abstract][Full Text] [Related]
22. Impact of incidental findings on integrated 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in patients with gastric cancer.
Tae CH; Lee JH; Choi JY; Min BH; Rhee PL; Kim JJ
Asia Pac J Clin Oncol; 2015 Mar; 11(1):34-40. PubMed ID: 25560093
[TBL] [Abstract][Full Text] [Related]
23. Incidental Detection of Urinary Leakage on FDG PET/CT Imaging for Staging of Gastric Cancer.
Kim DW; Kim MH; Kim CG
Clin Nucl Med; 2016 Mar; 41(3):217-8. PubMed ID: 26571444
[TBL] [Abstract][Full Text] [Related]
24. Performance of (18)F-FDG PET/CT as a postoperative surveillance imaging modality for asymptomatic advanced gastric cancer patients.
Lee DY; Lee CH; Seo MJ; Lee SH; Ryu JS; Lee JJ
Ann Nucl Med; 2014 Oct; 28(8):789-95. PubMed ID: 24965850
[TBL] [Abstract][Full Text] [Related]
25. A hepatoid adenocarcinoma of the stomach evaluated with (18)F-FDG PET/CT: intense (18)F-FDG uptake contrary to the previous report.
Seo HJ; Chung JK; Go H; Cheon GJ; Lee DS
Clin Nucl Med; 2014 May; 39(5):442-5. PubMed ID: 24152637
[TBL] [Abstract][Full Text] [Related]
26. PET/Computed Tomography in the Diagnosis and Staging of Gastric Cancers.
Malibari N; Hickeson M; Lisbona R
PET Clin; 2015 Jul; 10(3):311-26. PubMed ID: 26099669
[TBL] [Abstract][Full Text] [Related]
27. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
28. 18F-fluorodeoxyglucose positron emission tomography in uterine carcinosarcoma.
Ho KC; Lai CH; Wu TI; Ng KK; Yen TC; Lin G; Chang TC; Wang CC; Hsueh S; Huang HJ
Eur J Nucl Med Mol Imaging; 2008 Mar; 35(3):484-92. PubMed ID: 17952435
[TBL] [Abstract][Full Text] [Related]
29. Incremental diagnostic utility of gastric distension FDG PET/CT.
Le Roux PY; Duong CP; Cabalag CS; Parameswaran BK; Callahan J; Hicks RJ
Eur J Nucl Med Mol Imaging; 2016 Apr; 43(4):644-53. PubMed ID: 26487512
[TBL] [Abstract][Full Text] [Related]
30. Comparison between 18F-FDG PET/MRI and MDCT for the assessment of preoperative staging and resectability of gastric cancer.
Lee DH; Kim SH; Joo I; Hur BY; Han JK
Eur J Radiol; 2016 Jun; 85(6):1085-91. PubMed ID: 27161056
[TBL] [Abstract][Full Text] [Related]
31. Value of ¹⁸F-FDG PET/CT in the diagnosis of primary gastric cancer via stomach distension.
Ma Q; Xin J; Zhao Z; Guo Q; Yu S; Xu W; Liu C; Zhai W
Eur J Radiol; 2013 Jun; 82(6):e302-6. PubMed ID: 23434453
[TBL] [Abstract][Full Text] [Related]
32. 18 F-fluorodeoxyglucose positron emission tomography to evaluate recurrent gastric cancer: a systematic review and meta-analysis.
Wu LM; Hu JN; Hua J; Gu HY; Zhu J; Xu JR
J Gastroenterol Hepatol; 2012 Mar; 27(3):472-80. PubMed ID: 21916986
[TBL] [Abstract][Full Text] [Related]
33. 18F-FDG PET/CT in gastric lymphoepithelioma-like carcinoma.
Zhang Y; Li B; Hou J; Cai L; Shi H
Rev Esp Med Nucl Imagen Mol; 2016; 35(3):202-4. PubMed ID: 26746813
[No Abstract] [Full Text] [Related]
34. Hepatoid adenocarcinoma of the stomach: dual-time-point (18)F-FDG PET/CT findings.
Sun X; Li Y; Dong M; Li W; Xing L
Jpn J Radiol; 2014 Dec; 32(12):721-4. PubMed ID: 25287326
[TBL] [Abstract][Full Text] [Related]
35. An Unusual Case of Esophageal Carcinosarcoma on 18F-FDG PET/CT.
Li C; Tian Y; Chen J; Wen B; He Y
Clin Nucl Med; 2021 Aug; 46(8):659-660. PubMed ID: 33512947
[TBL] [Abstract][Full Text] [Related]
36. Unilateral ovarian metastasis from gastric mucinous adenocarcinoma visualized on FDG PET/CT.
Tamam MO; Mulazimoglu M; Kamali G; Eker O; Ozpacaci T
Eur Rev Med Pharmacol Sci; 2012 Oct; 16 Suppl 4():1-3. PubMed ID: 23090794
[TBL] [Abstract][Full Text] [Related]
37. Bilateral ovarian metastases from gastric carcinoma on FDG PET/CT.
Ho L; Wassef H; Nakla A; Henderson R
Clin Nucl Med; 2012 May; 37(5):524-7. PubMed ID: 22475913
[TBL] [Abstract][Full Text] [Related]
38. 18F-FLT PET/CT imaging is not competent for the pretreatment evaluation of metastatic gastric cancer: a comparison with 18F-FDG PET/CT imaging.
Zhou M; Wang C; Hu S; Zhang Y; Yao Z; Li J; Guo W; Zhang Y
Nucl Med Commun; 2013 Jul; 34(7):694-700. PubMed ID: 23604223
[TBL] [Abstract][Full Text] [Related]
39. Combined PET/CT by 18F-FDOPA, 18F-FDA, 18F-FDG, and MRI correlation on a patient with Carney triad.
Papadakis GZ; Patronas NJ; Chen CC; Carney JA; Stratakis CA
Clin Nucl Med; 2015 Jan; 40(1):70-2. PubMed ID: 25423347
[TBL] [Abstract][Full Text] [Related]
40. Krukenburg tumour: Role of 18F-FDG PET/CT in identifying the primary site.
Usmani S; Murad S; Kandari FA; Maraghy MA
J Pak Med Assoc; 2024 Mar; 74(3):597-598. PubMed ID: 38591310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]